| World’s First Auto-Focus, Auto-Alignment Fundus Camera
FREMONT, Calif. - NIDEK Inc. has released the worlds first auto-focus, auto-alignment non-mydriatic fundus camera. The AFC-210 Pro Photographer takes true 45 degree images, without any cropping, and very high resolution of 12.8 mega pixel images. This camera delivers superior diagnostic detail, meeting government standards and reading center criteria for diabetic retinopathy screening. The highly automated design is so simple to use that someone with limited experience can take professional-quality retina images after just a few minutes of guidance. The AFC-210 Pro Photographer is ideal for busy optometry or ophthalmology offices, where staff turnover can be a recurring challenge. With this camera, anyone can easily take excellent retina images, even externals. These high resolution images are optimal for early diagnostic diabetic screening.
BiCOM Reports Better-Than-Expected Results Due to Unique Tonometer ...
BiCOM Inc. at a recent conference call, reported better than expected results due to a successful launch and unexpected increase in sales of its recently introduced transpalpebral (through the eyelid) tonometer Diaton, a device used for Glaucoma detection. BiCOM is planning to expand to over 30 countries. The company has increased its outlook for 2007.
[ClickPress, Fri Apr 20 2007] BiCOM Inc. has obtained the FDA approval for Diaton tonometer back in April of 2006. This unique hand-held tonometer allows to measure intraocular pressure (IOP) through the eyelid, with no contact with cornea, no sterilization and without the use of anesthesia drops. Transpalpebral (Diaton) approach is ideal for patients with corneal concerns like conjunctivitis, edema, erosion, cornea pathology, high degree of ametropy or astigmatism, or acquiring IOPs following laser refractive and other corneal surgeries.
I've got an eyeful of trouble
I've written before about how I'll be upstairs, think of something I need that's in the kitchen, head down to get it and, once I'm there, I'll get myself a glass of water (not the thing I went downstairs to get), then go back upstairs, at which point I will realize the mission I set out on was not accomplished. And of course, there's the nearly daily occurrence of going to the fridge to get something but, once you've got the door open, you can't for the life of you remember what it is you need. My theory is the blast of cold air creates amnesia. A recent event has me worried that things are getting worse. I was in Charlottesville, Va., for a few days recently, attending a book festival, and because I am not a fan of waiting around in airports, decided to drive down and back.
Health Tips: Heart, alcohol, cleaning
By LIDIA WASOWICZ GIVE YOUR HEART A BREAK TODAYMost adults follow at least one of three ways heart specialists recommend for keeping the old ticker healthy -- but only a handful engage in all three. The American Heart Association says cardiovascular disease can be kept at bay by:-- avoiding tobacco,-- exercising regularly,-- watching one's weight.While 93 percent of those surveyed by the Agency for Healthcare Research and Quality were taking at least one of those preventive steps, only 18 percent took them all. The survey showed:-- more than half engaged in moderate to vigorous activity thrice weekly,-- more than three-quarters did not smoke,-- more than a third had a Body Mass Index, a weight-to-height measure that correlates to body fat, of under 25 -- below the level considered overweight or obese.Only 42 percent practiced two of these behaviors, and 6.5 percent practiced none at all.
Merck and Schering-Plough to Develop Another New Cholesterol ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co., Inc. (NYSE: MRK) announced today an agreement to commence development of an ezetimibe and atorvastatin combination product in collaboration with Schering-Plough Corporation. Merck and Schering-Plough are the two parent companies of Merck/Schering-Plough Pharmaceuticals, a joint venture that was formed in 2000 to develop and market in the United States new prescription medicines in cholesterol management and respiratory disease. The cholesterol collaboration was expanded in 2001 and includes worldwide markets (excluding Japan). The joint venture/partnership also markets ZETIA® (ezetimibe) and VYTORIN® (ezetimibe/simvastatin) in the U.S. and these medicines are marketed as EZETROL and INEGY, respectively, in many countries outside the U.S.
|
